Quick Answer
TENAX THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $2.12 million for the year ending 2022.
- TENAX THERAPEUTICS, INC. showed a decrease of -62.0% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
- This data is from TENAX THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2023.
- XBRL data for this metric is available from 1967 to 2022 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2022: $2.12 million | Fiscal year 2021: $5.58 million | Fiscal year 2020: $6.25 million | Fiscal year 2019: $4.91 million | Fiscal year 2018: $12.37 million | Fiscal year 2017: $1.60 million | Fiscal year 2016: $10.00 million | Fiscal year 2015: $3.66 million | Fiscal year 2015: $7.93 million | Fiscal year 2014: $58.32 million | Fiscal year 2013: $783.5 thousand | Fiscal year 2012: $1.88 million | Fiscal year 2011: $951.9 thousand | Fiscal year 2010: $632.7 thousand | Fiscal year 1967: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: